All In MedTech

FDA Clearance Tracker · P870072-S021

THORATEC VENTRICULAR ASSIST DEVICE (VAD) SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 14, 2003 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 14, 2003

Approved

Time to decision

250 days

Received Sep 6, 2002. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P870072-S021
Device name
THORATEC VENTRICULAR ASSIST DEVICE (VAD) SYSTEM
Applicant location
Berkeley, CA
Received
Sep 6, 2002
Decided
May 14, 2003
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P870072

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code DSQ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE USE OF A REVERSE-ENGINEERED DIRECTIONAL FLOW VALVE, TO BE MANUFACTURED AT THE SITE LOCATED IN PLEASANTON, CALIFORNIA.

Source documents

Other decisions for Thoratec Laboratories Corp.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.